Publications



A NOVEL APPROACH OF MALDI DRUG IMAGING, IMMUNOHISTOCHEMISTRY, AND DIGITAL IMAGE ANALYSIS FOR DRUG DISTRIBUTION STUDIES IN TISSUES


Katharina Huber, Annette Feuchtinger, Daniela Martina Borgmann, Zhoulei Li, Michaela Aichler, Stefanie M. Hauck, Horst Zitzelsberger, Markus Schwaiger, Ulrich Keller, and Axel Walch. (28-09-2014).

A NEXT-GENERATION DUAL-RECOMBINASE SYSTEM FOR TIME- AND HOST-SPECIFIC TARGETING OF PANCREATIC CANCER


Nina Schönhuber, Barbara Seidler, Kathleen Schuck, Christian Veltkamp, Christina Schachtler, Magdalena Zukowska, Stefan Eser, Thorsten B. Feyerabend, Mariel C. Paul, Philipp Eser, Sabine Klein, Andrew M. Lowy, Ruby Banerjee, Fangtang Yang, Chang-Lung Lee, Everett J. Moding, David G. Kirsch, Angelika Scheideler, Dario R. Alessi, Ignacio Varela, Allan Bradley, Alexander Kind, Angelika E. Schnieke, Hans-Reimer Rodewald, Roland Rad, Roland M. Schmid, Günter Schneider & Dieter Saur. (31-10-2014).

Nature America, 2014, doi:10.1038/nm.3646

PDF 1

PDF 2

PET IMAGING OF ONCOLYTIC VSV EXPRESSING THE MUTANT HSV-1 THYMIDINE KINASE TRANSGENE IN A PRECLINICAL HCC RAT MODEL


Kim A Muñoz-Álvarez, Jennifer Altomonte, Iina Laitinen, Sibylle Ziegler, Katja Steiger, Irene Esposito, Roland M Schmid and Oliver Ebert. (17-02-2015).

BIODISTRIBUTION AND RADIATION DOSIMETRY FOR THE CHEMOKINE RECEPTOR CXCR4-TARGETING PROBE 68GA-PENTIXAFOR


Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M. (19-02-2015).

IN VIVO MOLECULAR IMAGING OF CHEMOKINE RECEPTOR CXCR4 EXPRESSION IN PATIENTS WITH ADVANCED MULTIPLE MYELOMA


Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U. (03-03-2015).

DISRUPTION OF THE PRKCD-FBXO25-HAX-1 AXIS ATTENUATES THE APOPTOTIC RESPONSE AND DRIVES LYMPHOMAGENESIS


Baumann U, Fernández-Sáiz V, Rudelius M, Lemeer S, Rad R, Knorn AM, Slawska J, Engel K, Jeremias I, Li Z, Tomiatti V, Illert AL, Targosz BS, Braun M, Perner S, Leitges M, Klapper W, Dreyling M, Miething C, Lenz G, Rosenwald A, Peschel C, Keller U, Kuster B, Bassermann F. (24-11-2014).

GP130 ACTIVATION INDUCES MYELOMA AND COLLABORATES WITH MYC


Dechow T, Steidle S, Götze KS, Rudelius M, Behnke K, Pechloff K, Kratzat S, Bullinger L, Fend F, Soberon V, Mitova N, Li Z, Thaler M, Bauer J, Pietschmann E, Albers C, Grundler R, Schmidt-Supprian M, Ruland J, Peschel C, Duyster J, Rose-John S, Bassermann F, Keller U. (10-11-2014).

DIRECT PARAMETRIC IMAGE RECONSTRUCTION IN REDUCED PARAMETER SPACE FOR RAPID MULTI-TRACER PET IMAGING


Cheng X, Li Z, Liu Z, Navab N, Huang SC, Keller U, Ziegler S, Shi K. (10-02-2015).

DISCLOSING THE CXCR4 EXPRESSION IN LYMPHOPROLIFERATIVE DISEASES BY TARGETED MOLECULAR IMAGING


Hans Jürgen Wester, Ulrich Keller, Margret Schottelius, Ambros Beer, Kathrin Philipp-Abbrederis, Frauke Hoffmann, Jakub Šimeček, Carlos Gerngross, Michael Lassmann, Ken Herrmann, Natalia Pellegata, Martina Rudelius, Horst Kessler, Markus Schwaiger. (06-03-2015).

STAT3 INHIBITION REDUCES TOXICITY OF ONCOLYTIC VSV AND PROVIDES A POTENTIALLY SYNERGISTIC COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA


S Marozin, J Altomonte,  KA  Muñoz-Alvarez,  A  Rizzani, EN De Toni, WE Thasler,  RM Schmid  and  OEbert